Tag: MHR

Blue Horseshoe Stocks: MJMJ, MEET Recaps & More

MeetMe, Inc. MEET

Yesterday we tagged MEET for the first time since last year, and our timing in turning our attention back to it was excellent. On the strength of improved Q2 guidance published in a premarket PR, the stock made a healthy intraday move.

From a morning low of 1.66, MEET went on to hit an even 2.00 high toward the end of the session; a 20% swing. Volume was excessive, on the order of roughly 22x the 3-month average. Ideally, we need to see MEET maintain support at or above the new 200DMA of 1.74 on any pullbacks in order for us to remain interested.

The MaryJane Group, Inc. MJMJ

At the end of last week we were monitoring MJMJ for a bottom, After coming up off its bottom on Tuesday and providing us with a quality  opportunity, MJMJ continued to perform well with a nice intraday surge.

The stock made its way from an early low of .0036, and managed a subsequent high of .0055; a hefty 53% move.

From our observed low of .0027, we’ve seen an overall increase of 104% over a period of just a few sessions. With many cannabis stocks beginning to show increased signs of life lately, we’ll be sure to continue monitoring this play and others in the sector.

Cleveland BioLabs, Inc. CBLI

We want to keep an eye on CBLI after this morning’s big announcement (link below), which has essentially caused the stock to enter into Blue-Sky Breakout mode this morning, cracking through its 200DMA of 5.35 in the premarket. If it can maintain that 200DMA as support on an early pullback, we could see added increases.

Regardless, whenever we run across a stock in this position we’re always on the lookout for dip-and-rip scenarios to occur after a consolidation. It’s a pattern that we’ve seen played out time and time again.

Pazoo, Inc. PZOO

We also noticed a PR published on PZOO for the second consecutive day. After yesterday’s big announcement that the company had fully acquired MA & Associates’ marijuana testing business, today we learned that the company’s other subsidiary has signed a new, potentially lucrative distribution agreement.

Pazoo is another company that falls under the category of those doing everything they can to capitalize on the ever-expanding marijuana sector. It has remained extremely active in pursuing that goal over the entire time we’ve been tracking the stock.

Extended Watchlist:
RXMD, MHR, PTNT, RXII, BWEN, INVT

Blue Horseshoe Stocks: QIHU Update & More

Qihoo 360 Technology Co. Ltd. QIHU – Options
–
  On Tuesday, we floated a few options-trading ideas for QIHU, which had been trading up off of its recently registered annual lows in anticipation of the company Q4 earnings call. Despite positive figures the stock trailed off, however it reversed itself yesterday, lending strength to our short-term options targets.

We outlined our interest in the QIHU Weekly $48-49 Calls, and both sets of contracts enjoyed highly notable gains as QIHU traded in a range from 45.17-47.22. As a result, the $48’s increased from a daily low of .35 to as much as .75, marking a move of 114%

The $49’s fared quite well also, rising from a low of .25 to a subsequent high of .42, for total possible intraday gains equaling 68%

While our longer-term idea of the 03/27 $50 Calls were still too far from the money to begin a move of their own, we’re going to continue monitoring those over the next few weeks as the stock may not yet be done trending up. One particularly apt outlook report on QIHU comes from UBS analysts, who recently upgraded their price target for the stock to $85/share.

Added Note:

This week has been a good one with regard to stocks being discussed in our trader’s *chatroom, and serves as a good example of why we invite our readers to participate.

First, Propanc Health Group Corp. PPCH, which ran an incredible 483% after one of our members brought it forth on Tuesday, we saw some of that momentum carried into yesterday. Starting out the day at .0237, the stock spiked to a subsequent high of .042 for an intraday gain of 77% before consolidating into the close.

Also a topic of conversation in our *chatroom yesterday was Hear AtLast Holdings, Inc. HRAL, and it too caused quite a stir on its chart. From an early low of .0014 (9:34AM EDT, two minutes after we tagged it in the room), HRAL rocketed its way to a high of .0055; a 293% intraday rip!

*Want to get involved with our daily trading chats? Simply add “stocksumo” as a contact on Skype and request access. It’s as easy as that!

Extended Watchlist:
SDRL, LEVY, PVCT, MHR, GFN

Blue Horseshoe Stocks: LPCN Recap, LPDX & More

Lipocine, Inc. LPCN

LPCN served up an opportunity at some decent intraday gains after appearing on yesterday morning’s extended watchlist.

The stock played out a classic dip and rip scenario, falling to a morning low of 6.89 before surging back in the afternoon to a subsequent high of 8.42. That offered traders a chance at intraday gains of up to 22% on plenty of liquidity- the stock would trade 23.5X its 30-day average volume.

The productive session came on the heels of the company announcing favorable results from Phase-3 clinical testing of “LPCN 1021”, its oral treatment for low testosterone >>> VIEW PR

LipoScience, Inc. LPDX

LPDX is gapping up heavily in the premarket, and the interesting story behind it is one that we’re definitely going to want to give our close attention. Early this morning, the company announced that it was the subject of a buyout that would be executed at a share price of $5.25. Barely an hour later, another PR hit the LPDX newswire, concerning an investigation of the managerial board’s handling of the deal, and whether or not they have secured the best possible buyout price.

According to the investigative firm leading the case, “The $5.25 per share acquisition price is far less than where the stock has recently traded. In fact, on January 25, 2013, LipoScience stock opened for trading at $9.75 the day the Company sold 5.0 million shares of stock in its initial public stock offering.” >>> VIEW PR

The playing out of this scenario is going to be an interesting story moving forward, which is why we wanted to flag LPDX this morning, and fill everyone in on this morning’s happenings. The possibility that the investigation could lead to a potential restructuring of the buyout is enough to have us keep our ears to the tracks on this one for the foreseeable future.

Magnum Hunter Resources Corp. MHR

MHR is another morning gapper that we’re putting on our radars. This morning Magnum announced impressive throughput volumes on its “Eureka Hunter” gas gathering pipeline. According to the CEO, “increased capacity has resulted in a record day of approximately 316,500 MMBtu of natural gas”. >>> VIEW PR

Options Trading Idea: PBR Calls 

We’re interested in the PBR October 31st $15.50 Calls  last traded at 1.88. If we can see PBR make its way back to recent $20+ highs within a month, it could put us in position to see returns of up to 150-200% on those contracts.

Extended Watchlist:
 RNN, MNKD, CNET, VHC, MPET

Blue Horseshoe Stocks: RSH Coming Off 52-Week Lows

Radio Shack Corp. RSH

The last time RSH appeared in one of our reports was back in mid-May, and we’ve passively monitored the stock’s gradual consolidation over the few months since. On Tuesday, it registered an annual low of .55, and in each of the proceeding sessions, has maintained higher lows as the stock hints at a rebound.

Where a week ago we were looking at a steadily declining chart, we now appear to have one with several indicators turning in a favorable direction, and the price action is responding in kind.

What we want to see now, is a break of the 20DMA of .74 to really confirm that the stock is in recovery mode. We always like running across stocks coming off their 52-week lows, so we’re going to be monitoring the stock more heavily in coming sessions. The included snapshot below illustrates the indications of a ripening chart:

Med-Cannabis Pharma, Inc. MCPI

MCPI began to pull back yesterday after providing us with a good opportunity for gains this week. When all was said and done, we saw an overall increase of 55% from .355-.55, which is quite a respectable move.

In instances such as these, when profit-taking from a rapid move up creates a dip, we like to wait in the wings observing for a low point where we might collect cheap shares to ride into the next upswing.

We also want to keep an eye out for further updates on the three retail marijuana stores the company is setting up in the towns of Port Townsend, Port Hadlock, and Hood Canal, Washington.

Extended Watchlist:
JCP, MHR, VGL, DEJ, SPPI

Blue Horseshoe Stocks: REVO, DEWM & Extended Watchlist

Revolutionary Concepts, Inc. REVO

We placed REVO on watch back on February 6th following news of a share reduction, and at the time, the stock was trading at .0022. We are very pleased to report that yesterday, just six sessions later, the stock ran to a new high of .0297. That’s a mega-spike of 1250% in just over a week, and one of a host of quadruple-digit gainers that we’ve passed along to our readers thus far in 2014.

The momentum in this stock is enticing, so we’re certainly going to be open to the possibility of carryover through to next week. At the same time, we’ve seen these scenarios take a different route enough times to remain skeptical. Most of the time, these huge gainers will undergo a consolidation period, which is when we give it our full attention, because a properly-timed bottom can lead to serious gains on the bounce.

We prepared a video of the REVO chart that you can view by clicking below:

Dewmar International, Inc. DEWM

DEWM has been extremely kind to us in the short time since we first mentioned it on Monday (low of .0036), at which time it served us up roughly 45% in cumulative intraday gains. On Tuesday, we were afforded the chance at a 66% intraday gain as the stock ran from .0051 to .0085. At that point we had seen DEWM trade up 136% from our initial alert low.

Yesterday DEWM continued to push the envelope in a big way, reaching all the way up to .021, an astounding 483% move above Monday’s low!

Despite already having other products currently for sale in Walmart stores (as we mentioned on Monday), news out yesterday shows that the company is also serious about moving into the cannabis sector:

HOUSTON, TX, Feb 13, 2014 (Marketwired via COMTEX) — Dewmar International BMC, Inc. (OTCQB: DEWM) (OTCBB: DEWM) (“Dewmar” or “Company”) today announced that it has entered into a one year distribution agreement with C+SWISS, the original and first hemp-based ice tea ever distributed in the United States. The agreement gives Dewmar the exclusive right to distribute the hemp-based ice tea nationwide to one of the world’s largest retailers. The distribution agreement, effective immediately, continues Dewmar’s recently announced initiatives to become one of the most successful licensees and creators of hemp-based products in the United States.

www.DewmarInternational.com

Extended Watchlist:
CYBK, LIVE, NEWL, LCAV, SYMX, MHR

Get Our FREE Daily Reports!

SUBSCRIBE